Conversation

Running proposed medical research studies through IRB is about to get more exciting. I’ve never had to put a “what happens if the grant goes up in smoke in the middle” section in, but folks will need to start considering that. There is a huge ethical problem with starting people on a trial intervention (for instance, new cancer drug), only to suddenly stop all treatment, follow up, and data collection. How does one plan for that?!?